• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK NEUROFORM ATLAS 4.0MM X 30MM NO TIP- PMA; STENT, INTRACRANIAL NEUROVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK NEUROFORM ATLAS 4.0MM X 30MM NO TIP- PMA; STENT, INTRACRANIAL NEUROVASCULAR Back to Search Results
Model Number M003UZAS40300
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Infarction, Cerebral (1771)
Event Date 10/07/2017
Event Type  Injury  
Manufacturer Narrative
This is the first of 2 reports.Subject device remains implanted.
 
Event Description
It was reported that 1-month post-procedure of stent-assisted coiling with two subject stents, the patient experienced ischemic stroke with regressive right paresis and slurred speech.Kardegic 75mg/day medication was stopped 15 days before the adverse event date.This adverse event of ischemic stroke was assessed as non-serious and was resolved, without sequelae the next day.
 
Manufacturer Narrative
The intended use for the device was for treatment.The reported complaint could not be confirmed and it could not be definitively determined if the device failed to meet specifications because the product was not returned.Due to the automated mes system (manufacturing execution system), there are controls in the manufacturing process to ensure the product met specifications upon release.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.An assignable cause of anticipated procedural complication will be assigned to the reported event as a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted with the directions for use, product labeling and/or risk documentation files.
 
Event Description
It was reported that 1-month post-procedure of stent-assisted coiling with two subject stents, the patient experienced ischemic stroke with regressive right paresis and slurred speech.Kardegic 75mg/day medication was stopped 15 days before the adverse event date.This adverse event of ischemic stroke was assessed as non-serious and was resolved, without sequelae the next day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROFORM ATLAS 4.0MM X 30MM NO TIP- PMA
Type of Device
STENT, INTRACRANIAL NEUROVASCULAR
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
MDR Report Key10242107
MDR Text Key197848159
Report Number3008881809-2020-00198
Device Sequence Number1
Product Code NJE
UDI-Device Identifier07613327382181
UDI-Public07613327382181
Combination Product (y/n)N
PMA/PMN Number
P180031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,study
Type of Report Initial,Followup
Report Date 09/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/07/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2022
Device Model NumberM003UZAS40300
Device Catalogue NumberM003UZAS40300
Device Lot Number19643585
Was Device Available for Evaluation? No
Date Manufacturer Received09/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
NEUROFORM ATLAS STENT (STRYKER); NEUROFORM ATLAS STENT (STRYKER)
Patient Outcome(s) Other;
Patient Age49 YR
-
-